A person’s immune response to variants of SARS-CoV-2, the virus that causes COVID-19, depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.
Alzheimer’s Drug in Smaller Vial Sizes Could Save Medicare Hundreds of Millions
Current lecanemab vial sizes lead to 5.8% waste, a study suggested. An estimated $133 million to $336 million worth of lecanemab may be discarded every
October 15, 2024